We have developed a mobile phone proof-of-concept iKey biometric APP to verify an image of the ONH with an accuracy of 97.06%. The small ONH, as opposed to the larger retina, was chosen for this biometric development for two reasons: it lies close to the macula, behind the pupil, allowing for easy image capture with even a small pupil for a mobile phone owner, and the ONH contains the uniquely positioned retinal blood vessels and nerve fibers, previously only visible to ophthalmologists, reflecting local and systemic health.
Verification will fail if the ONH image does not map onto a previously enrolled image. Asymptomatic changes to the ONH can occur for many reasons, including aging, disease, healing, or deterioration for subclinical reasons. The capture of the image may also be hampered by media changes, such as cataract and vitreous opacities.
Lightweight portable retinal cameras are widely available, furthermore, several fundus camera lens adaptors have already received full US Food and Drug Administration (FDA) approval for using the mobile phone as an ophthalmoscope.
19
Once the image is enrolled in the iKey APP, a silent continuous record is accumulated and may be simultaneously processed by all platform DNNs (see
Fig. 1).
The ONH contains the root of the uniquely patterned retinal vessels allowing for easy capture with even a small pupil. There is a growing demand for a safe biometric for vulnerable groups, such as children, for digital onboarding and cybersecurity.
20 The iKey verification accuracy of 97.06% surpasses that of face recognition technology,
21 currently hampered as a biometric because of coronavirus disease 2019 (COVID-19) induced mask wearing.
22 Unlike face or iris recognition, a live image of the ONH is internal and gaze evoked, so it cannot be unknowingly captured or altered.
There is potential for iKey to be used from an early age not just for sight protection but also for general health maintenance. The iKey can work as part of a multimodal platform allowing analysis by other DNNs.
Two of the most common causes of preventable blindness in the world,
8 diabetic retinopathy and glaucoma, can occur with silent ONH changes.
Diabetic retinopathy is already being screened using the Remidio-adapted android mobile phone offline as an edge device.
23 Glaucoma-screening algorithms are more challenging.
24 The current lack of clinical consensus on diagnosis of structural or functional changes in glaucoma
25 hampers the clinical parameters used to train DNNs with adequate sensitivity. The precise pathogenesis of glaucoma remains to be established, but ONH vasculature changes with silent glaucoma.
26–30 Wang et al. have demonstrated the importance of mechanical shearing factors on cribriform plate and remodeling, with maximum shearing forces along the vessels.
31 Retinal blood vessel shifts have been postulated to be strongly linked with biomechanical forces and differential tissue deformation, including changes to the ONH shape, with rapidly progressive glaucoma.
32 Optical coherence tomography (OCT) and B scan analysis has also confirmed peripapillary age-related tissue remodeling.
33 Preliminary results on age classification of a limited database of children are promising, the subject of a future report on the completed dataset (author communication, and safe data collection currently curtailed by the COVID pandemic).
Thakur et al. developed a DNN to predict future glaucoma on color photographs of ONH, which progressed to develop glaucomatous optic neuropathy.
34 Mendex-Hernandez et al. have reported equivalent sensitivity to glaucoma detection using fast cost-effective colorimetric on color fundus photographs.
35
Jammal et al
36 have suggested the use of M2M DNN training, using DNNs trained with images of patients with known retinal nerve fiber layer (RNFL) and functional loss to train diagnostic DNNs on color fundus images of the same patients in order to improve detection of fast glaucoma progressors. Bowd et al.
37 have combined machine learning gradient-boosting classifiers combining optical coherence tomography angiography (OCTA) and OCT macula and ONH measurements to predict glaucoma.
Future iKey DNNs with feature relationship change mapping using OCT, spectral domain-OCT (SD-OCT), and OCTA images will be included in the multimodal APP. The ability to alert to specific vessel feature change within a short time of the event may allow more time specific correlation with structural RNFL and perimetric changes.
ONH vessels have been affected systemic vascular conditions
38,39 as well as cerebral small vessel disease
5 and the homology among the retina, cerebral vascular features, and diseases, such as Alzheimer’s disease is well established.
7 The iKey may have a much broader role for disease prevention and health monitoring, as with other wearable technology.
40 Future work will include the relationship of nonvascular features around the vascular framework within the geometric graticular space.
There are several limitations to this initial development of the iKey platform and all will be addressed with ongoing research.
The database comprises a filtered predominantly Caucasian Irish diabetic population with normal nonmyopic fundi. The iKey is verifying existing features, not making a diagnosis, so it could be expected to make no difference with mixed populations, but this remains to be confirmed in future work over a broader demographic. It is known that the ONH area ranges from 1.8 mm to up to 6 mm in various populations.
41 Interindividual variability of the optic disc area
16 and refractive errors can cause significant distortion of the ONH image.
42 We designed the GBV DNN in iKey to map vectors on the intersection of the blood vessels with a concentric graticule in order to avoid optical errors due to aberrant refractive distortion of the rim appearance and for potential mechanical change detection research with progressive myopia.
The BVSF mapping is designed to optimize verification as a biometric, by mapping features common to unique vessel patterns on both images. The GBV DNN is, however, based on mapping an identical group of blood vessel vectors to optimize detection of specific blood vessel changes. There were 11.15% that failed to verify with the GBV but were successful with BVSF. In addition, 2.56% failed with BVSF but succeeded with GBV. We plan to test iKey verification on images of the ONH, which have actually developed changes, such as manifest glaucomatous optic neuropathy and disc hemorrhages, and are commencing a prospective longitudinal study of the same. In the interim, we performed a limited experiment to verify an ONH before and after applying a fake hemorrhage, drawn with Procreate APP software and an Apple pencil (
Fig. 8).
The GBV failed to verify, as expected, with occlusion of the BV features, whereas the BVSF accurately verified the unique features common to both images despite the hemorrhage. This suggests that the GBV algorithm is superior, as hoped for, at detection of change over the blood vessel feature map, but it is too small an experiment to confirm. Future research will explore improving sensitivities with modifications of graticule shape, size, and vector bin size.
Another limitation of this study was due to problems with the variety of cameras used on a retrospective dataset. The verification accuracy of 97.06% was on a dataset where error analysis on the false negative results (198 pairs) demonstrated 95 pairs would not have been included according to data preprocessing protocols and 58 were due to technical cropping failure. Eight different fundus cameras were used for these data from the national diabetic screening service, mandating an image normalization process to equalize pixel content. The iKey has been designed to include use at a one-one verification level with a self-owned fundus camera, where the image will be re-taken if unsatisfactory. Correct data preprocessing and good image capture would have resulted in a verification accuracy of 98%.
Other vessel-centered methods of cropping will be explored to improve accuracy further.
Some images had obvious signs of media opacities, as would be expected with this diabetic data set. Uni-ocular visual field loss is often asymptomatic, being obscured by the contralateral visual field. Capture failure due to media opacities may have inherent screening benefits for a diabetic or aging population.
Cropping was successful below a blur index of 9%. The successful BVSF verification of some blurred images was surprising, underpinning the sensitivity of the feature-trained DNN. Further research will explore the benefits of lowering the blur threshold further, versus the possible loss of feature change detection at too high a blur level.
A strength of the iKey biometric is that it provides a motive for the APP owner to have their ONH image, ensuring its concomitant availability, not only for all data protection, including health-clouds, but also for use with the growing pool of multimodal diagnostic retinal algorithms revealing new biomarkers. The iKey offers a unique ability to detect change. Longitudinal studies incorporating this at the point of structural change of the various features in the future might allow timely intervention at the earliest opportunity to halt functional loss. Future work will include supervised DNNs trained on nonvascular features around the vascular framework within the iKey graticules.
Here, we present a hybrid platform of ONH algorithms based on mapping of ONH vascular features for use on a smartphone in order to anticipate silent structural change before functional loss. It could facilitate the real time, longitudinal, self-monitoring of our optic discs as markers for ocular and systemic disease. It could join other dashboards of diagnostic algorithms
42 with great potential to narrow the gap in access to preventative health care measures irrespective of global location.